This year’s been a big deal for big deals in pharma, biotech and medtech: There have been 869 deals worth $354.3 billion, according to a new Mergermarket report – the most the firm’s seen since 2001 by value. This is attributed, of course, to the eight megadeals this year – representative of the mass consolidation […]
A survey of healthcare and life science professionals and investors suggests healthcare M&A activity will surge past 2013 levels when there were 394 deals valued at $97 billion. The report by Bass Berry & Sims and Mergermarket indicates that market disruption, brought on by the Affordable Care Act, will lead to more consolidation deals across […]
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.